Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Malcolm Forbes, MBBS

Articles by Malcolm Forbes, MBBS

© BOSNIAN/SHUTTERSTOCK.COM

Treatment Options in Late-Life Treatment-Resistant Depression

ByKatarina Arandjelovic, MBBS,Harris A. Eyre, MD, PhD,Malcolm Forbes, MBBS,Helen Lavretsky, MD, MS

May 17th 2016

This article sheds light on the strengths and weaknesses of various approaches to TRD management in adults 60 years and older.

Latest Updated Articles

Treatment Options in Late-Life Treatment-Resistant Depression
May 17th 2016

Trending on Psychiatric Times

The Real-World Burden of Adult ADHD

How Prevalent Is Simultaneous Alcohol-Cannabis Use?

Why Extended-Release Stimulants Are First-Line for ADHD

When to Switch Schizophrenia Treatment

Rapid Antidepressants and Suicide Risk: What Do We Really Know?